Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997

SEC filing history

Showing 751-775 of 936 matching filings.

Per page
25
Current page
31
4

MAIN DOCUMENT DESCRIPTION

Filing date
30 Jul 2013
Reporting date
26 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
25 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
25 Jul 2013
Reporting date
22 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
19 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
18 Jul 2013
Reporting date
17 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
18 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-22873

CT ORDER filing

Filing date
16 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
01 Jul 2013
Reporting date
28 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
18 Jun 2013
Reporting date
13 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-198133

D filing

Filing date
17 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
14 Jun 2013
Reporting date
12 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-51477

SC 13G/A

Filing date
14 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
06 Jun 2013
Reporting date
04 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
06 Jun 2013
Reporting date
06 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-51477

SABBY 13G ABIO 06.03.13

Filing date
03 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
30 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
30 May 2013
Reporting date
29 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-187508

EFFECT filing

Filing date
29 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-187508

FORM S-1/A

Filing date
24 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-187508

FORM S-1/A

Filing date
15 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-22873

FORM 8-K/A

Filing date
09 May 2013
Reporting date
02 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .